Cargando…

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial

BACKGROUND: This open-label, multicentre, phase 2 trial evaluated the efficacy and tolerability of the mammalian target of rapamycin inhibitor ridaforolimus in women with advanced endometrial cancer. METHODS: Women with measurable recurrent or persistent endometrial cancer and documented disease pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colombo, N, McMeekin, D S, Schwartz, P E, Sessa, C, Gehrig, P A, Holloway, R, Braly, P, Matei, D, Morosky, A, Dodion, P F, Einstein, M H, Haluska, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619076/ https://www.ncbi.nlm.nih.gov/pubmed/23403817 http://dx.doi.org/10.1038/bjc.2013.59

Ejemplares similares

Ridaforolimus
Publicado: (2012)

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens
por: Krasner, C N, et al.
Publicado: (2007)

Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells
por: Morgan, Sherif S, et al.
Publicado: (2014)

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer
por: Becker, Marc A., et al.
Publicado: (2016)

A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors
por: Pearson, Andrew D.J., et al.
Publicado: (2016)

A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer
por: Lush, Richard M., et al.
Publicado: (2012)

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents
por: Moxley, Katherine M., et al.
Publicado: (2010)

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
por: Brana, I, et al.
Publicado: (2014)

Treating metastatic soft-tissue or bone sarcomas – potential role of ridaforolimus
por: Keedy, Vicki L
Publicado: (2012)

Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models
por: SQUILLACE, RACHEL M., et al.
Publicado: (2012)

Pharmacokinetic Evaluation of a DSPE-PEG(2000) Micellar Formulation of Ridaforolimus in Rat
por: Remsberg, Connie M., et al.
Publicado: (2012)

A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
por: Liu, Lian, et al.
Publicado: (2013)

Prescribing in Northern Ireland. Study No. 2: systematic anti-infectives.
por: Elmes, P. C., et al.
Publicado: (1978)

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers
por: Chon, Hye Sook, et al.
Publicado: (2017)

Are we as depressed as we think we are?
por: King, D. J., et al.
Publicado: (1977)

Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors
por: Seki, Yoshitaka, et al.
Publicado: (2011)

Necessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion
por: Lee, Taek Sang, et al.
Publicado: (2010)

Prescribing in Northern Ireland. Study no. 1: Sleeping tablets.
por: Elmes, P. C., et al.
Publicado: (1976)

Annual report for 1976 of the Belfast Poisons Information Service.
por: McMeekin, C., et al.
Publicado: (1978)

Annual Report for 1977 of the Belfast Poisons Information Service.
por: McMeekin, C., et al.
Publicado: (1979)

Patients’ Preferences Regarding Osteoarthritis Medications: An Adaptive Choice-Based Conjoint Analysis Study
por: Al-Omari, Basem, et al.
Publicado: (2020)

Desmoplastic Small Round Cell Tumor, a “Floating Island” Pattern in Pleural Fluid Cytology: A Case Report and Review of the Literature
por: Zhu, Hui, et al.
Publicado: (2015)

Retrospective observational study of emergency admission, readmission and the ‘weekend effect’
por: Shiue, Ivy, et al.
Publicado: (2017)

Reducing the futile transportation of out-of-hospital cardiac arrests: a retrospective validation
por: House, Matthew, et al.
Publicado: (2018)

A Density of Ramified Primes
por: Chan, Stephanie, et al.
Publicado: (2021)

Recent Advances in Endometrial Cancer
por: Tran, Arthur-Quan, et al.
Publicado: (2017)

Can Aging in Place Be Cost Effective? A Systematic Review
por: Graybill, Erin M., et al.
Publicado: (2014)

Systematic Review of Studies Using Conjoint Analysis Techniques to Investigate Patients’ Preferences Regarding Osteoarthritis Treatment
por: Al-Omari, Basem, et al.
Publicado: (2021)

Association between body mass index (BMI) and [(123)I]Ioflupane (DaTSCAN) availabilities in patients with parkinsonism using single-photon emission computed tomography–computed tomography (SPECT-CT)
por: Parekh, Puja, et al.
Publicado: (2023)

Ability of individuals with chronic hemiparetic stroke to locate their forearms during single-arm and between-arms tasks
por: Gurari, Netta, et al.
Publicado: (2018)

Economic evaluations on centralisation of specialised healthcare services: a systematic review of methods
por: Bhattarai, Nawaraj, et al.
Publicado: (2016)

How methodological frameworks are being developed: evidence from a scoping review
por: McMeekin, Nicola, et al.
Publicado: (2020)

Defining major trauma: a pre-hospital perspective using focus groups
por: Thompson, Lee, et al.
Publicado: (2019)

An analysis of the policy responses to the COVID-19 pandemic in France, Belgium, and Canada
por: Desson, Zachary, et al.
Publicado: (2020)

Role of TGF-β signaling in uterine carcinosarcoma
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2015)

Tailoring the sampling time of single-sample GFR measurement according to expected renal function: a multisite audit
por: McMeekin, Helena, et al.
Publicado: (2022)

Protein Thermodynamics Can Be Predicted Directly from Biological Growth Rates
por: Corkrey, Ross, et al.
Publicado: (2014)

The Biokinetic Spectrum for Temperature
por: Corkrey, Ross, et al.
Publicado: (2016)

Correction: The Biokinetic Spectrum for Temperature
por: Corkrey, Ross, et al.
Publicado: (2016)

The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis
por: Kok, P.-S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k7i7l0ifq0r1l7fe89gqrnencv